Thomas C. Hutsell

753 total citations
17 papers, 636 citations indexed

About

Thomas C. Hutsell is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Thomas C. Hutsell has authored 17 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Surgery. Recurrent topics in Thomas C. Hutsell's work include Nitric Oxide and Endothelin Effects (7 papers), Cardiac Imaging and Diagnostics (2 papers) and Biochemical effects in animals (2 papers). Thomas C. Hutsell is often cited by papers focused on Nitric Oxide and Endothelin Effects (7 papers), Cardiac Imaging and Diagnostics (2 papers) and Biochemical effects in animals (2 papers). Thomas C. Hutsell collaborates with scholars based in United States. Thomas C. Hutsell's co-authors include Larry K. Keefer, Daniel L. Mooradian, Stephen R. Hanson, Daniel J. Smith, Keith M. Davies, Joseph E. Saavedra, Sharon K. Pulfer, Michael L. Citro, Joseph A. Hrabie and Debashish Chakravarthy and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Journal of Medicinal Chemistry.

In The Last Decade

Thomas C. Hutsell

17 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas C. Hutsell United States 12 269 128 127 100 91 17 636
Charlotte Farah France 10 229 0.9× 222 1.7× 203 1.6× 51 0.5× 72 0.8× 11 842
Koichi Kondo Japan 15 167 0.6× 343 2.7× 167 1.3× 53 0.5× 65 0.7× 60 888
Lauriane Y. M. Michel Belgium 12 256 1.0× 388 3.0× 223 1.8× 64 0.6× 79 0.9× 21 944
Koji Ichimori Japan 10 345 1.3× 237 1.9× 105 0.8× 53 0.5× 42 0.5× 10 798
Frédérique Lantoine France 11 353 1.3× 194 1.5× 80 0.6× 30 0.3× 61 0.7× 13 714
Thomas W. Smith United States 17 233 0.9× 686 5.4× 410 3.2× 95 0.9× 121 1.3× 27 1.4k
Murali C. Krishna United States 7 190 0.7× 189 1.5× 43 0.3× 41 0.4× 31 0.3× 8 656
A. A. Timoshin Russia 15 270 1.0× 262 2.0× 54 0.4× 30 0.3× 110 1.2× 59 875
Chiming Wei United States 18 140 0.5× 398 3.1× 244 1.9× 63 0.6× 126 1.4× 49 1.2k
Jeremy Wright United States 17 278 1.0× 290 2.3× 62 0.5× 15 0.1× 66 0.7× 41 741

Countries citing papers authored by Thomas C. Hutsell

Since Specialization
Citations

This map shows the geographic impact of Thomas C. Hutsell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas C. Hutsell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas C. Hutsell more than expected).

Fields of papers citing papers by Thomas C. Hutsell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas C. Hutsell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas C. Hutsell. The network helps show where Thomas C. Hutsell may publish in the future.

Co-authorship network of co-authors of Thomas C. Hutsell

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas C. Hutsell. A scholar is included among the top collaborators of Thomas C. Hutsell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas C. Hutsell. Thomas C. Hutsell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Przyklenk, Karin, Thomas C. Hutsell, Katsuya Hata, & Peter Whittaker. (1998). Targeted Coronary Thrombolysis via “Pericardial” Administration of Lytic Agents?. Journal of Thrombosis and Thrombolysis. 6(2). 83–88. 1 indexed citations
2.
Chen, Changyi, S R Hanson, Larry K. Keefer, et al.. (1997). Boundary Layer Infusion of Nitric Oxide Reduces Early Smooth Muscle Cell Proliferation in the Endarterectomized Canine Artery. Journal of Surgical Research. 67(1). 26–32. 27 indexed citations
3.
Kaul, Sanjay, Tasneem Z. Naqvi, Michael C. Fishbein, et al.. (1997). Local Delivery of an Ultra-short-acting Nitric Oxide- releasing Compound, DMHD/NO, Is Highly Effective in Inhibiting Acute Platelet-Thrombus Formation on Injured Arterial Strips. Journal of Cardiovascular Pharmacology and Therapeutics. 2(3). 181–193. 4 indexed citations
4.
Smith, Daniel J., Debashish Chakravarthy, Sharon K. Pulfer, et al.. (1996). Nitric Oxide-Releasing Polymers Containing the [N(O)NO]-Group. Journal of Medicinal Chemistry. 39(5). 1148–1156. 151 indexed citations
5.
Hampl, Václav, Martin Tristani‐Firouzi, Thomas C. Hutsell, & Stephen L. Archer. (1996). Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertension.. PubMed. 31(1). 55–62. 44 indexed citations
6.
Kaul, Sanjay, Raj Makkar, Masato Nakamura, et al.. (1996). Inhibition of Acute Stent Thrombosis Under High-Shear Flow Conditions by a Nitric Oxide Donor, DMHD/NO. Circulation. 94(9). 2228–2234. 24 indexed citations
7.
Hanson, Stephen R., Thomas C. Hutsell, Larry K. Keefer, Daniel L. Mooradian, & Daniel J. Smith. (1995). Nitric Oxide Donors: A Continuing Opportunity in Drug Design. Advances in pharmacology. 34. 383–398. 40 indexed citations
8.
Mooradian, Daniel L., Thomas C. Hutsell, & Larry K. Keefer. (1995). Nitric Oxide (NO) Donor Molecules. Journal of Cardiovascular Pharmacology. 25(4). 674–678. 199 indexed citations
9.
Kaul, Sanjay, Tasneem Z. Naqvi, Michael C. Fishbein, et al.. (1995). 1901-121 Profound Inhibition of Arterial Thrombosis by a Novel Nitric Oxide Donor. Journal of the American College of Cardiology. 25(2). 34A–34A. 4 indexed citations
10.
Karim, Aziz, et al.. (1976). Spironolactone. III. Canrenone—maximum and minimum steady‐state plasma levels. Clinical Pharmacology & Therapeutics. 19(2). 177–182. 25 indexed citations
11.
Karim, Aziz, et al.. (1976). Spironolactone. II. Bioavailability. Clinical Pharmacology & Therapeutics. 19(2). 170–176. 20 indexed citations
12.
Hutsell, Thomas C., et al.. (1975). Determination of disopyramide and its mono-N-dealkylated metabolite in blood serum and urine. Journal of Chromatography A. 106(1). 151–158. 46 indexed citations
13.
Ranney, R. E., Štěpán Mareš, Raymond E. Schroeder, Thomas C. Hutsell, & Frederick M. Radzialowski. (1975). The phenylalanine and tyrosine content of maternal and fetal body fluids from rabbits fed aspartame. Toxicology and Applied Pharmacology. 32(2). 339–346. 12 indexed citations
15.
Mackerer, Carl R., et al.. (1973). Effects of clofibrate, in vitro, on mitochondrial respiration and oxidative phosphorylation. Biochemical Pharmacology. 22(4). 513–519. 23 indexed citations
16.
Hutsell, Thomas C., et al.. (1970). Effects of Dietary Alterations on Insulin Secretion in Normal Individuals. Military Medicine. 135(8). 631–635. 2 indexed citations
17.
Cortese, Thomas A., et al.. (1969). Experimental Friction Blisters in Macaque Monkeys**From the Dermatology Research Division, Letterman Army Institute of Research, San Francisco, California 94129.. Journal of Investigative Dermatology. 53(2). 172–177. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026